Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 26 Melanoma 25 Stomach Neoplasms 9 Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Hodgkin Disease 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Carcinoma 2 Brain Neoplasms 2

Interventions

Fluorouracil 2 Vincristine 1 Paclitaxel 1 Nivolumab 1 Leucovorin 1 Ipilimumab 1 Gemcitabine 1 FAPI-46 1 Etoposide 1 Epirubicin 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms, Unknown Primary × Nivolumab × Clear all

NCT04131621 2020-04-15

CheCUP

University Hospital Heidelberg

Phase 2 Unknown

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡